Samsung Biologics, Top Search Ranking... Stock Price -1.31%
As of 9:30 AM on the 15th, Samsung Biologics is trading at 604,000 KRW, down 1.31% from the previous day. This represents a 12.06% increase compared to April 13. Samsung Biologics is known as the bio business holding company of the Samsung Group.
Over the past five days, individual investors have net sold 246,891 shares, while foreign investors and institutions have net bought 184,517 shares and 96,451 shares, respectively.
On May 13, Samsung Biologics was a market topic with the headline "New high despite prosecution investigation."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
